Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SINOVAC BIOTECH LTD.

(SVA)
  Report
 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Estimated financial data (e) (USD)
Sales 2019 246 M - -
Net income 2019 44,9 M - -
Net cash position 2019 183 M - -
P/E ratio 2019 15,8x
Yield 2019 -
Sales 2020 511 M - -
Net income 2020 110 M - -
Net cash position 2020 1 040 M - -
P/E ratio 2020 6,66x
Yield 2020 -
Capitalization 642 M 642 M -
EV / Sales 2019 1,86x
EV / Sales 2020 -0,78x
Nbr of Employees 1 959
Free-Float 24,1%
More Financials
Company
Sinovac Biotech Ltd. (Sinovac) is a holding company. The Company is a biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases, including hepatitis A, hepatitis B, seasonal influenza, Haemagglutinase5 Neuraminidase1 (H5N1) and Influenza A (H1N1) pandemic influenza and mumps. The Company's pipeline consists of... 
Sector
Pharmaceuticals
Calendar
05/04Earnings Release
More about the company
All news about SINOVAC BIOTECH LTD.
01/05Zhejiang Jinyi Shengshi Bioengineering Co., Ltd. announced that it has received $31.4 m..
CI
01/04WHO sees more evidence that Omicron causes milder symptoms
RE
2021Sinovac COVID-19 shot with Pfizer booster less effective against Omicron - study
RE
2021Sinovac Biotech Swings to H1 Profit Amid Sales Boost
MT
2021SINOVAC BIOTECH : Reports Unaudited First Half of 2021 Financial Results - Form 6-K
PU
2021SINOVAC Reports Unaudited First Half of 2021 Financial Results
BU
2021Sinovac Biotech Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
CI
2021Refugees lack COVID shots because drugmakers fear lawsuits - documents
RE
2021SINOVAC BIOTECH : Antigua Court of Appeal Rules in Favor of SINOVAC, Upholds 2018 Judgment..
PU
2021Antigua Court of Appeal Rules in Favor of SINOVAC, Upholds 2018 Judgment
BU
2021Omicron is a wake-up call for COVID-19 vaccine developers
RE
2021SINOVAC BIOTECH : Beijing Settled Litigation of Its Business License and Seals - Form 6-K
PU
2021Sinovac Biotech Settles Court Case Related to Business License
MT
2021SINOVAC Beijing Settled Litigation of Its Business License and Seals
BU
2021Mexico eyes COVID-19 vaccine booster shots, especially for older adults
RE
More news
News in other languages on SINOVAC BIOTECH LTD.
2021Sinovac Biotech réalise un bénéfice au premier semestre grâce à l'augmentation des vent..
2021Sinovac Biotech Ltd. annonce ses résultats pour le semestre clos le 30 juin 2021
2021CORONA-BLOG/Sinovac bietet "unzureichenden" Schutz gegen Omikron - Studie
2021CORONA-BLOG/China genehmigt Testreihe mit zwei Corona-Vakzinen
2021NINGBO ZHOUSHAN PORT : Puerto de contenedores del este de China suspende actividad por cas..
More news
Chart SINOVAC BIOTECH LTD.
Duration : Period :
Sinovac Biotech Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Wei Dong Yin Chairman, President, CEO, Secretary & MD
Nan Wang CFO & Vice President-Business Development
Qiang Gao Chief Operating Officer & Vice President
Yuk Lam Lo Independent Director
Jian Li Independent Director
Sector and Competitors
1st jan.Capi. (M$)
SINOVAC BIOTECH LTD.0.00%642
CSL LIMITED-11.13%88 334
WUXI BIOLOGICS (CAYMAN) INC.-7.56%46 306
SAMSUNG BIOLOGICS CO.,LTD.-13.62%43 094
ALEXION PHARMACEUTICALS, INC.0.00%40 336
BIOGEN INC.-7.34%32 656